Melatonin Suppresses Renal Cortical Fibrosis by Inhibiting Cytoskeleton Reorganization and Mitochondrial Dysfunction through Regulation of miR-4516

Renal fibrosis, a major risk factor for kidney failure, can lead to chronic kidney disease (CKD) and is caused by cytoskeleton reorganization and mitochondrial dysfunction. In this study, we investigated the potential of melatonin treatment to reduce renal fibrosis by recovering the cytoskeleton reorganization and mitochondrial dysfunction. We found that miR-4516 expression was downregulated in the renal cortex of CKD mice and P-cresol-treated TH1 cells. Decreased miR-4516 expression stimulated cytoskeleton reorganization and mitochondrial dysfunction, and induced renal fibrosis. Melatonin treatment suppressed fibrosis by inhibiting cytoskeleton reorganization and restoring mitochondrial function via increased miR-4516 expression. More specifically, melatonin treatment increased miR-4516 expression while decreasing ITGA9 expression, thereby inhibiting cytoskeleton reorganization. In addition, increased expression of miR-4516 by melatonin treatment reduced ROS formation and restored mitochondrial function. These findings suggest that melatonin may be a promising treatment for patients with CKD having renal fibrosis. Moreover, regulation of miR-4516 expression may be a novel strategy for the treatment of renal fibrosis.

[1]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[2]  J. H. Lee,et al.  Melatonin‐stimulated exosomes enhance the regenerative potential of chronic kidney disease‐derived mesenchymal stem/stromal cells via cellular prion proteins , 2020, Journal of pineal research.

[3]  J. H. Lee,et al.  Melatonin Enhances Mitophagy by Upregulating Expression of Heat Shock 70 kDa Protein 1L in Human Mesenchymal Stem Cells under Oxidative Stress , 2019, International journal of molecular sciences.

[4]  Valérie Metzinger-Le Meuth,et al.  miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools , 2019, Non-coding RNA research.

[5]  R. Beroukhim,et al.  miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma , 2018, Oncogene.

[6]  Cheng Yang,et al.  Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury , 2018, Cell Death & Disease.

[7]  J. H. Lee,et al.  Pioglitazone Protects Mesenchymal Stem Cells against P-Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1 , 2018, International journal of molecular sciences.

[8]  J. H. Lee,et al.  Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein. , 2018, Anticancer research.

[9]  S. Yun,et al.  Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin p-Cresol via Inhibiting mTOR-Dependent Autophagy , 2017, Biomolecules & therapeutics.

[10]  N. Saini,et al.  miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[11]  J. Vallée,et al.  Diagnosis and assessment of renal fibrosis: the state of the art. , 2017, Swiss medical weekly.

[12]  J. H. Lee,et al.  Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression , 2017, Journal of pineal research.

[13]  R. Chen,et al.  Role of microRNA-4516 involved autophagy associated with exposure to fine particulate matter , 2016, Oncotarget.

[14]  Mitsuo Kato,et al.  Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases. , 2016, American journal of physiology. Renal physiology.

[15]  P. Olinga,et al.  Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes , 2015, Front. Med..

[16]  M. Breuning,et al.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease. , 2015, Journal of the American Society of Nephrology : JASN.

[17]  R. Neubig,et al.  Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. , 2014, American journal of physiology. Cell physiology.

[18]  Songming Huang,et al.  Mitochondrial dysfunction in the pathophysiology of renal diseases. , 2014, American journal of physiology. Renal physiology.

[19]  Q. Mi,et al.  The regulation and function of micrornas in kidney diseases , 2013, IUBMB life.

[20]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[21]  J. Chun,et al.  LPA1‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  T. Hewitson Fibrosis in the kidney: is a problem shared a problem halved? , 2012, Fibrogenesis & tissue repair.

[23]  R. Reiter,et al.  Melatonin membrane receptors in peripheral tissues: Distribution and functions , 2012, Molecular and Cellular Endocrinology.

[24]  Aaron N. Chang,et al.  MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways , 2012, Science Translational Medicine.

[25]  Luca Scorrano,et al.  The relationship between mitochondrial shape and function and the cytoskeleton. , 2006, Biochimica et biophysica acta.

[26]  M. Couillard,et al.  Overexpression of PKD1 Causes Polycystic Kidney Disease , 2006, Molecular and Cellular Biology.

[27]  Jiahuai Han,et al.  β-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death , 2004, Journal of Cell Science.

[28]  Lindsay N. Carpp,et al.  A role for the actin cytoskeleton in cell death and aging in yeast , 2004, The Journal of cell biology.

[29]  Gregory R Pond,et al.  The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[30]  P. Barrett,et al.  Melatonin receptors in the human fetal kidney: 2-[125I]iodomelatonin binding sites correlated with expression of Mel1a and Mel1b receptor genes. , 1998, The Journal of endocrinology.

[31]  G. Brown,et al.  Studies of the renal action of melatonin: evidence that the effects are mediated by 37 kDa receptors of the Melia subtype localized primarily to the basolateral membrane of the proximal tubule , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.